Insiders / Kewalramani Reshma / Activity
Activity — Kewalramani Reshma
20 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | Grant | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $0 | +16K +12.23% | 149,813 0.06% of shares | low |
| Jan 22, 2026 | Grant | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $0 | +12K +8.31% | 154,825 0.06% of shares | low |
| Jan 22, 2026 | Grant | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $0 | +27K +23.26% | 142,940 0.06% of shares | low |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $57.8K | -120 -0.09% | 137,758 0.05% of shares | low |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $115.9K | -240 -0.17% | 137,518 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $191.9K | -400 -0.29% | 137,878 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $225.1K | -460 -0.35% | 131,270 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $466.2K | -949 -0.74% | 127,596 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $857.2K | -2K -1.72% | 98,278 0.04% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.22M | -3K -1.83% | 135,008 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.24M | -3K -1.98% | 125,076 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.34M | -3K -2.08% | 128,545 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.60M | -3K -2.43% | 131,730 0.05% of shares | medium |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $1.73M | -3K -2.80% | 121,578 0.05% of shares | medium |
| Feb 24, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $2.42M | -5K -3.48% | 138,278 0.05% of shares | low |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $2.97M | -6K -5.66% | 100,003 0.04% of shares | medium |
| Feb 17, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $3.17M | -7K -4.37% | 143,259 0.06% of shares | low |
| Feb 10, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $3.89M | -8K -5.36% | 146,528 0.06% of shares | low |
| Feb 13, 2026 | Other | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $6.36M | -13K -8.90% | 133,487 0.05% of shares | low |
| Feb 27, 2026 | Sell | VRTX Vertex Pharmaceuticals Inc / Ma Common Stock | $7.72M | -16K -12.81% | 105,998 0.04% of shares | medium |